Literature DB >> 8965059

Reported comorbidity of mental disorders with substance abuse among psychiatric inpatients in Israel.

J Rabinowitz1, M Mark, M Popper, M Slyuzberg.   

Abstract

In preparation for shifting of care from psychiatric hospital to the community, the prevalence of substance abuse comorbidity among discharged psychiatric patients was studied. Such patients are not usually treated by substance abuse programs or mental health clinics. Data from the Israeli National Psychiatric Case Registry were analyzed on reported substance abuse among all 53,379 psychiatric discharges during 1989-92. The Registry consists of data that physicians are mandated to report on all patients. The authors found that reported substance abuse comorbidity was 13.2% for males and 3.6% for females. Patients with a diagnosis of personality disorder had the most reported substance abuse. Reported drug abuse for males increased with age until age 45, and alcohol abuse until age 65. Drug and alcohol abuse by females is the highest for the patients under age 24 and declines with an increase in age. The results were almost identical for each of the four years studied. The results suggest that developing special outpatient facilities to serve this group will be impractical because of the small numbers. Ways of serving these patients in existing community mental health centers are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8965059     DOI: 10.1007/bf02521030

Source DB:  PubMed          Journal:  J Ment Health Adm        ISSN: 0092-8623


  18 in total

1.  Screening for substance abuse in hospitalized psychiatric patients.

Authors:  R W Kanwischer; J Hundley
Journal:  Hosp Community Psychiatry       Date:  1990-07

2.  Diagnosing alcoholism.

Authors:  J W Smith
Journal:  Hosp Community Psychiatry       Date:  1983-11

3.  Cost-effectiveness of substance disorder interventions for people with severe mental illness.

Authors:  J M Jerrell; T W Hu; M S Ridgely
Journal:  J Ment Health Adm       Date:  1994

4.  Predicting revolving-door patients in a 9-year national sample.

Authors:  J Rabinowitz; M Mark; M Popper; M Slyuzberg; H Munitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

5.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

6.  Position statement on the need for improved training for treatment of patients with combined substance use and other psychiatric disorders.

Authors: 
Journal:  Am J Psychiatry       Date:  1994-05       Impact factor: 18.112

7.  Substance abuse by young adult chronic patients.

Authors:  D J Safer
Journal:  Hosp Community Psychiatry       Date:  1987-05

Review 8.  Schizophrenia and substance abuse.

Authors:  J A Selzer; J A Lieberman
Journal:  Psychiatr Clin North Am       Date:  1993-06

9.  Symptom severity and utilization of treatment resources among dually diagnosed inpatients.

Authors:  R Ries; M Mullen; G Cox
Journal:  Hosp Community Psychiatry       Date:  1994-06

Review 10.  Current epidemiology of comorbidity of psychiatric and addictive disorders.

Authors:  N S Miller; J Fine
Journal:  Psychiatr Clin North Am       Date:  1993-03
View more
  2 in total

1.  The SES setting of psychiatric hospitalization in Israel.

Authors:  Daphna Levinson; Max Lachman; Yaakov Lerner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-02-22       Impact factor: 4.328

2.  Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.

Authors:  Raj K Kalapatapu; Aimee Campbell; Efrat Aharonovich; Mei-Chen Hu; Frances R Levin; Edward V Nunes
Journal:  J Addict Med       Date:  2013 Jan-Feb       Impact factor: 3.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.